The ultra-cushioned Nike LeBron 19 line will be offered with leopard print, likely referencing the basketball icon's "killer instinct."
The shoe, unveiled ahead of the "Space Jam: A New Legacy" film, is the Los Angeles Lakers star's 19th signature basketball pair.
It retains the high-top trim of the last previous models and is equipped with handfuls of Air Max units across the upper and sole unit.
The synthetic and textile components found throughout most of the sneaker have varying shades of black and white, while the mesh base reveals the orange leopard print.
There are the "LJ" logos near the vamp and miniature swooshes at the lateral heel.
Underfoot, the shoe has a dual-chambered Air proposition and robust tread solution.
So far, Nike.com hasn't announced an official US release date.


US Dollar Weakens as Iran Talks Boost Risk Appetite in Forex Market
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
Los Angeles Mayor Says White House Must Reassure Fans Ahead of FIFA World Cup
U.S.-Iran Tensions Escalate as Strait of Hormuz Crisis Disrupts Global Oil Markets
Bank of England Set to Hold Interest Rates as Inflation Risks and Iran War Impact Loom
‘The geezer game’ – a nearly 50-year-old pickup basketball game – reveals its secrets to longevity
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
Trump Threatens Stadium Deal Over Washington Commanders Name
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
Oil Price Forecasts Rise for 2026 as Middle East Supply Risks Persist
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Trump to Host UFC Event at White House on His 80th Birthday
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 



